Onex Canada Asset Management’s GSK GSK Stock Holding History

Onex Canada Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-23,984	Closed	-$921K	–	95
2025 Q2	$921K	Sell	23,984 -22,243	-48%	-$850K	0.11%	98
2025 Q1	$1.79M	Buy	+46,227	New	+$1.69M	0.23%	89
2024 Q3	–	Sell	-137,680	Closed	-$2.66M	–	113
2024 Q2	$2.66M	Sell	137,680 -130,000	-49%	-$5.47M	0.3%	97
2024 Q1	$5.77M	Sell	267,680 -45,000	-14%	-$1.86M	0.58%	54
2023 Q4	$5.78M	Sell	312,680 -4,920	-2%	-$177K	0.57%	57
2023 Q3	$5.78M	Buy	317,600 +95,600	+43%	+$3.39M	0.44%	76
2023 Q2	$3.92M	Buy	+222,000	New	+$7.96M	0.24%	103
2022 Q1	–	Sell	-408,100	Closed	-$11.1M	–	151
2021 Q4	$11.1M	Buy	+408,100	New	+$21.2M	0.45%	69

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Onex Canada Asset Management's GSK Position: Q3 2025 in Review

Onex Canada Asset Management sold out of GSK (GSK) in Q3 2025, closing a stake of 23,984 shares — an estimated $921K sold.

Onex Canada Asset Management first reported a position in GSK in Q4 2021 and held it in 8 quarters. The position peaked at $11.1M in Q4 2021. 896 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

Onex Canada Asset Management reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
Onex Canada Asset Management sold 23,984 GSK shares in Q3 2025, an estimated $921K.
Onex Canada Asset Management first reported a position in GSK in Q4 2021 and held it in 8 quarters.
Onex Canada Asset Management's GSK position peaked at $11.1M in Q4 2021.
896 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Onex Canada Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.